BRIEF-Biocept says Selecto blood-based test will now be accessible to patients in Mexico through agreement with Quest Diagnostics
April 18 (Reuters) - Biocept Inc
* Target selecto blood-based test will now be accessible to patients in mexico through reference agreement with quest diagnostics mexico
* Says terms of transaction were not disclosed Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.